WHO ICTRP trial
A multi-center randomized controlled clinical trial on treatment of chronic…
ChiCTR-TRC-12002116 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TRC-12002116 |
|---|---|
| Public title | A multi-center randomized controlled clinical trial on treatment of chronic hepatitis C using Vitamin D combine pegylated interferon + ribavirin |
| Scientific title | A multi-center randomized controlled clinical trial on treatment of chronic hepatitis C using Vitamin D combine pegylated-interferon-alpha-2a+ ribavirin |
| Primary sponsor | Department of Infectious Deases of First Teaching Hospital of Xinjiang Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Countries | China |
| Conditions | Hepatitis C |
| Interventions | Trial:vitamin D + peg-INF-alpha-2a;Control:peg-INF-alpha-2a |
| Registration date | Apr 18, 2012 |
| Target size | Trial:100;Control:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: